Pharmacokinetics of Testosterone Lotion in the Treatment of Hypogonadal Males
Phase 2
Completed
- Conditions
- Hypogonadism
- Registration Number
- NCT00372008
- Lead Sponsor
- Acrux DDS Pty Ltd
- Brief Summary
Testosterone replacement treatment is the most effective way of treating hypogonadism in men. Acrux has a proprietry testosterone replacement product - Testosterone-MD Lotion, and this study will evaluate the efficacy and safety of this product.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Male
- Target Recruitment
- 40
Inclusion Criteria
- Hypogonadal males between 18-70 years old with qualifying general medical health
Exclusion Criteria
- Disqualifying concurrent conditions or allergy/sensitivity to testosterone replacement therapy
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- CROSSOVER
- Primary Outcome Measures
Name Time Method Pharmacokinetic
- Secondary Outcome Measures
Name Time Method Safety and tolerability
Trial Locations
- Locations (1)
Birmingham
🇺🇸Birmingham, Alabama, United States